Latest News & Features
.jpg/r%5Bwidth%5D=1280&r%5Bheight%5D=720/7f40fd90-a367-11f0-96cc-07b8dae1da3b-Untitled%20design%20(1).webp)
Americas
The pharma giant will share rights to new innovations with an AI-driven organoid platform designed to produce fully human antibodies in weeks. 7 October 2025
Big Pharma
Can AI tools raise the bar for inventiveness? And when algorithms become as productive as living systems, will they make their own outputs unpatentable? Industry experts unpick AI drug discovery’s biggest issues. 6 October 2025
Careers
The new recruits, who join the firm’s LA and NYC offices, bring specialisms in technology, commerce, pharma, agriculture and biotechnology. 6 October 2025
Careers
Life sciences specialist boosts its London office with an expert in small molecules, biologics, and gene therapy before UK courts, the UPC, and the EPO. 3 October 2025
Americas
A spike in agency investigations and more female lead counsel still leave a notable gender gap at the venue, find Troutman Pepper Locke’s Emma Mann, Gwendolyn Tawresey, Brittany Reeves, and Gillian Schutt. 3 October 2025
Americas
From stalled drug approvals to suspended patent investigations, US rightsholders face mounting uncertainty during the federal freeze. 2 October 2025
Americas
As a US federal shutdown grips IP-critical agencies, layoffs, office closures, and resource cutbacks are underway at the US Patent and Trademark Office. 2 October 2025
Americas
As John Squires makes the bold move to allow patentability of an AI-related invention in Ex parte Desjardins, experts broadly welcome the decision—but encourage some caution, finds Sarah Speight. 2 October 2025
Americas
Research reveals an increase in global filings in 2024/2025, but concerns remain over the future of vaccine development in the US. 1 October 2025
Americas
The healthtech giant has convinced a US court to freeze the assets of two Chinese startups and their ex-employees for breaching an injunction for trade secret theft of X-ray tubes used in CT scanners. 1 October 2025